| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Dr. Rhonda Patrick | Q109301171 |
| P2860 | cites work | Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion | Q48775504 |
| (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats | Q48788625 | ||
| APOE ε4 differentially influences change in memory performance depending on age. The SMART-MR study | Q48906484 | ||
| Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. | Q51053469 | ||
| Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. | Q51646100 | ||
| Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers. | Q53238833 | ||
| Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. | Q53273541 | ||
| Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study. | Q53347902 | ||
| Alzheimer's disease | Q60313667 | ||
| Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain | Q72850709 | ||
| The physiology and regulation of the intestinal absorption and transport of omega-3 and omega-6 fatty acids | Q93514672 | ||
| Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2 | Q24314295 | ||
| Characterization of plasma unsaturated lysophosphatidylcholines in human and rat | Q24531892 | ||
| Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial | Q24607545 | ||
| Brain fuel metabolism, aging, and Alzheimer's disease | Q24625859 | ||
| Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba | Q24634419 | ||
| Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease | Q24656640 | ||
| Clearance systems in the brain-implications for Alzheimer disease | Q26801541 | ||
| Neuropathological alterations in Alzheimer disease | Q27003314 | ||
| Marine omega-3 phospholipids: metabolism and biological activities | Q27690878 | ||
| Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid | Q28115048 | ||
| Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium | Q28252389 | ||
| Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers | Q28271343 | ||
| Phospholipases A₁ | Q28305868 | ||
| Interactive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy elders | Q28384123 | ||
| Mfsd2a is critical for the formation and function of the blood-brain barrier | Q28507996 | ||
| Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown | Q33717021 | ||
| Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. | Q33717326 | ||
| Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults | Q33768448 | ||
| Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain | Q34322444 | ||
| Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. | Q34322455 | ||
| O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease | Q34333004 | ||
| Sleep Fragmentation and the Risk of Incident Alzheimer's Disease and Cognitive Decline in Older Persons | Q34354571 | ||
| Reversal of cognitive decline: a novel therapeutic program | Q34461143 | ||
| Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome | Q34477725 | ||
| Apolipoprotein E: From lipid transport to neurobiology | Q34497951 | ||
| Dietary patterns and risk of dementia: the Three-City cohort study. | Q34584817 | ||
| Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial | Q34804070 | ||
| Human apolipoprotein E ɛ4 expression impairs cerebral vascularization and blood-brain barrier function in mice | Q34976193 | ||
| Apolipoprotein E regulates the integrity of tight junctions in an isoform-dependent manner in an in vitro blood-brain barrier model | Q34978900 | ||
| Blood-brain barrier breakdown in the aging human hippocampus | Q35151019 | ||
| Metabolic profiling distinguishes three subtypes of Alzheimer's disease | Q36100673 | ||
| Phospholipid and fatty acid specificity of endothelial lipase: potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues | Q36168147 | ||
| Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation. | Q36455090 | ||
| Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease | Q36468141 | ||
| Regulation between O-GlcNAcylation and phosphorylation of neurofilament-M and their dysregulation in Alzheimer disease | Q36488821 | ||
| GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration | Q36526013 | ||
| Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease | Q36615510 | ||
| Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A. | Q36849973 | ||
| The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition | Q37006519 | ||
| Enhanced incorporation of dietary DHA into lymph phospholipids by altering its molecular carrier | Q37015178 | ||
| The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease | Q37054938 | ||
| Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study | Q37310717 | ||
| Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep | Q37384609 | ||
| Higher efficacy of dietary DHA provided as a phospholipid than as a triglyceride for brain DHA accretion in neonatal piglets | Q37603235 | ||
| The use of PET in Alzheimer disease | Q37688880 | ||
| DHA may prevent age-related dementia | Q37698014 | ||
| Plasma phospholipids identify antecedent memory impairment in older adults. | Q37714213 | ||
| Physical activity reduces hippocampal atrophy in elders at genetic risk for Alzheimer's disease. | Q37734864 | ||
| ApoE and Aβ in Alzheimer's disease: accidental encounters or partners? | Q38190156 | ||
| Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brain. | Q38192243 | ||
| 2015 Alzheimer's disease facts and figures | Q40928952 | ||
| Microglia function in Alzheimer's disease | Q41014561 | ||
| Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice. | Q41193473 | ||
| Regulation of the plasma non-esterified fatty acid concentration in the postprandial state | Q41571831 | ||
| A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome | Q41928079 | ||
| Structural elucidation of molecular species of pacific oyster ether amino phospholipids by normal-phase liquid chromatography/negative-ion electrospray ionization and quadrupole/multiple-stage linear ion-trap mass spectrometry | Q42205596 | ||
| Positional Distribution of Fatty Acids in Triacylglycerols and Phospholipids from Fillets of Atlantic Salmon (Salmo Salar) Fed Vegetable and Fish Oil Blends. | Q42391686 | ||
| Reversal of cognitive decline in Alzheimer's disease | Q42433808 | ||
| n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier | Q42521884 | ||
| Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. | Q42547641 | ||
| Bioavailability of marine n-3 fatty acid formulations | Q42967046 | ||
| Glucose transport and utilization are altered in the brain of rats deficient in n-3 polyunsaturated fatty acids. | Q44030470 | ||
| Regioisomers of phosphatidylcholine containing DHA and their potential to deliver DHA to the brain: role of phospholipase specificities | Q44965942 | ||
| Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. | Q46011960 | ||
| Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models. | Q46019370 | ||
| Dietary alpha-linolenic acid and health-related outcomes: a metabolic perspective. | Q46200000 | ||
| Comparison of molecular species of various transphosphatidylated phosphatidylserine (PS) with bovine cortex PS by mass spectrometry | Q46784547 | ||
| Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. | Q46786077 | ||
| DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial | Q48117600 | ||
| Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. | Q48126715 | ||
| Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study | Q48371548 | ||
| Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. | Q48376822 | ||
| Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease | Q48453732 | ||
| Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting | Q48573957 | ||
| GLUT-1 expression in the cerebra of patients with Alzheimer's disease | Q48589517 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| phosphatidylcholine | Q650187 | ||
| P304 | page(s) | 1554-1564 | |
| P577 | publication date | 2018-10-05 | |
| 2019-02-01 | |||
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease | |
| P478 | volume | 33 |
| Q64244953 | Apolipoprotein E4 Alters Astrocyte Fatty Acid Metabolism and Lipid Droplet Formation | cites work | P2860 |
Search more.